Corius
CORIUS Group is the largest dermatology and phlebology practice network in Germany, Switzerland, and the Netherlands, operating 91 MVZ clinics with 320 doctors and 1,562 employees that treat approximately 1.4 million patients annually, funded by Ufenau Capital Partners.
- Company typePrivate
- Founded2017
- HeadquartersMünchen, Germany
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Corius does
CORIUS Group, founded in 2017 and headquartered in Munich, is the largest dermatology and phlebology practice network in Germany, Switzerland, and the Netherlands. The company operates 91 locations employing 320 doctors and 1,562 staff, treating approximately 1.4 million patients annually. It provides general dermatology, skin cancer prevention, allergology, dermatosurgery, aesthetic medicine, laser treatments, and phlebology services through owned and integrated Medizinische Versorgungszentren (MVZ) clinics. Brands of acquired practices are largely retained, and the group operates a centralized back-office for administrative, IT, HR, and purchasing functions.
The company's business model is a healthcare services roll-up: CORIUS acquires dermatology and phlebology practices — primarily those whose owners are approaching retirement — at a pace of roughly 4–5 acquisitions per year, integrates them into its network while retaining local brands, and benefits from group purchasing, shared clinical standards, and reduced administrative burden for physicians. It is financed by Ufenau Capital Partners, a Swiss private equity firm focused on healthcare services. Technology deployment includes AI-assisted skin cancer screening via FotoFinder devices and various therapeutic laser systems, with internal training supported through the CORIUS Academy and an annual medical conference.
Revenue is generated from medical services billed under statutory and private health insurance schemes in Germany, Switzerland, and the Netherlands. Terms are not publicly disclosed. Marketing is conducted through a corporate blog, podcast ("Mit Haut und Haar"), social media channels (Instagram, TikTok, LinkedIn, YouTube, Facebook), and press releases. The company's stated strategic objective is to become the leading dermatology and phlebology group in Europe, evidenced by continued cross-border acquisitions and expansion into new German federal states.
Corius firmographics
Firmographics- Name
- Corius
- Legal name
- Corius Deutschland GmbH
- Website
- https://corius.de
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- CORIUS Group is the largest dermatology and phlebology practice network in Germany, Switzerland, and the Netherlands, operating 91 MVZ clinics with 320 doctors and 1,562 employees that treat approximately 1.4 million patients annually, funded by Ufenau Capital Partners.
- Ownership category
- akta.pro rank
Corius industry classification
Industry- Product category
- Dermatology & Phlebology Healthcare Services
- NAICS
- Offices of Physicians (6211), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- General & Medical Dermatology (HLAKACAA)
- akta.pro secondary industries
- Dermatopathology (HLAKACAC), Psoriasis & Eczema Specialty Care (HLAKACAL), Dermocosmetics & Medical-Grade Skincare (CRABAAAF)
Keywords
Where Corius is headquartered
LocationHeadquarters
- HQ city
- München
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
Corius business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Medical Services Revenue: Revenue generated from providing dermatological and phlebological medical services to patients across the network of practices and clinics in Germany, Switzerland, and the Netherlands.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Corius product offering
Product offeringCore offering
Corius Group operates the largest dermatological and phlebological medical practice network in Germany, Switzerland, and the Netherlands, with 91 practice locations staffed by more than 320 doctors. The network delivers general dermatology, skin cancer prevention and screening, allergy testing, dermatosurgery, laser-based aesthetic treatments, allergology, and phlebology (vascular medicine) services, treating approximately 1.4 million patients annually through statutory and private health insurance reimbursement.
Differentiator
Problem solved
Functional benefit
Products and services
- Dermatology & Phlebology Practice Network Integrated network of dermatology and phlebology practice locations delivering general dermatology, skin cancer screening and prevention, allergy testing, dermatosurgery, aesthetic medicine, laser treatments, allergology, and phlebology care to patients across Germany, Switzerland, and the Netherlands. Services are billed through statutory and private health insurance schemes.
- Practice Succession Services Acquisition and integration program for independent dermatology and phlebology practice owners, primarily in Germany, Switzerland, and the Netherlands, providing succession planning, administrative relief, technology investment, and ongoing network affiliation. Targets owners approaching retirement; the group acquires an average of 4-5 practices per year.
Quantifiable outcome
- 1.4 million patients treated annually across the network
Companies that use Corius
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
Corius technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability2 records
Feature2 records
Corius partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Fachklinik HornheideminorCORIUS's ÜBAG Hautzentren Oldenburger Land collaborates with Fachklinik Hornheide, one of Europe's most renowned clinics for skin tumours, for especially serious dermatological cases requiring specialized treatment.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Corius competitors and assessment
Company assessmentBroad incumbents
- Sana Kliniken AG: Major German private hospital operator with a broad portfolio of inpatient and outpatient services. Comparable as a large-scale, multi-site German healthcare provider with ambulatory care programs, though broader than CORIUS's dermatology focus.
- Helios (Fresenius): Largest private hospital operator in Europe, part of Fresenius. While much larger and broader than CORIUS, it shares the multi-site, multi-specialty German ambulatory and inpatient care model and represents a potential strategic acquirer.
- Asklepios Kliniken: One of Germany's largest private hospital groups, operating a wide network of inpatient facilities and outpatient centers. Overlaps with CORIUS as a large multi-site German healthcare provider, though focused on broader hospital services.
- Artemed Group: German private hospital and healthcare group operating multiple specialty facilities. Comparable as a multi-site German healthcare operator with overlapping ambulatory and specialty capabilities.
- Schoen Klinik: German private hospital group with a network of specialty clinics across Germany and the UK. Comparable multi-site specialty healthcare operator in Germany, although focused on inpatient specialty care rather than ambulatory dermatology.
Direct peers
- Dermanence: German dermatology clinic chain providing medical and aesthetic dermatology. Operates a similar multi-location specialty clinic model in Germany and competes for the same patient base and acquisition targets.
- CentroDerm: German dermatology practice network offering general and aesthetic dermatology across multiple locations. Closely comparable to CORIUS in terms of specialty (dermatology), geography (Germany), and multi-clinic operating model.
- Bergman Clinics: Dutch-focused chain of specialist ambulatory clinics with multiple locations across the Netherlands. Directly comparable to CORIUS as a multi-location specialist clinic network operating in one of CORIUS's key markets, with a similar focus on focused, high-volume specialty care.
Emerging players
- Dermatologikum Berlin: Large, single-location specialist dermatology center in Germany offering comprehensive dermatology including dermatosurgery and aesthetic services. Comparable as a high-end German dermatology specialist, though singular rather than networked.
- skin + more: Smaller German dermatology practice chain focused on medical and aesthetic dermatology. Comparable in service mix and target customer base, though at a smaller scale and less geographically extensive than CORIUS.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Corius social profiles
Digital presenceCorius compliance and trust
Trust signalCompliance2 records
Corius financial estimates
Financial estimateRevenue estimate
Valuation estimate
Corius leadership team
Management profileNumber of profiles
Profiles4 records
Corius subsidiaries and ownership
Company hierarchySubsidiaries22 records
Corius funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Corius M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Corius
What does Corius do?
Corius Group operates the largest dermatological and phlebological medical practice network in Germany, Switzerland, and the Netherlands, with 91 practice locations staffed by more than 320 doctors. The network delivers general dermatology, skin cancer prevention and screening, allergy testing, dermatosurgery, laser-based aesthetic treatments, allergology, and phlebology (vascular medicine) services, treating approximately 1.4 million patients annually through statutory and private health insurance reimbursement.
Is Corius a public or private company?
Corius is a private company. It is classified as private equity controlled and is currently operating.
When was Corius founded?
Corius was founded in 2017. It employs 501 to 1,000 people.
Where is Corius based?
Corius is headquartered in München, Germany, in the Europe region.
How does Corius make money?
One revenue line is on record: medical Services Revenue.
Who are Corius's main competitors?
Broad incumbents on record are Sana Kliniken AG, Helios (Fresenius), Asklepios Kliniken, Artemed Group and Schoen Klinik. Direct peers are Dermanence, CentroDerm and Bergman Clinics. Emerging players are Dermatologikum Berlin and skin + more.
Does Corius have an API?
No public API is recorded for Corius.
What industry is Corius in?
Corius's product category is Dermatology & Phlebology Healthcare Services. Its primary akta.pro industry code is HLAKACAA, General & Medical Dermatology, with a secondary code of HLAKACAC, Dermatopathology. Its NAICS code is 6211 and its SIC code is 8011.